Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kensey Nash
Exton, Pennsylvania, United Stateskenseynash.com ↗
- Ownership
- Private
- Employees
- ~325
- Development stage
- Other
01
Overview
Kensey Nash developed and commercialized leading medical devices for vascular closure, notably the Angio-Seal Vascular Closure Device, as well as a broad portfolio of regenerative medicine products using proprietary collagen and synthetic polymers. Its technologies were widely adopted in cardiology, orthopedics, sports medicine, spine, endovascular procedures, and general surgery. The company was recognized for innovation in resorbable biomaterials.
- Therapeutic areas
- OtherCardiovascularNeurology
- Modalities
- DeviceCollagen-based biomaterialSynthetic polymer-based biomaterial
- Industry
- Surgical Medical Devices
02
Partnerships
St. Jude Medical (licensed manufacturer/distributor of Angio-Seal device)Strategic partners across multiple medical markets
Beyond the preview
Go deeper on Kensey Nash.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kensey Nash.